{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:32:14Z","timestamp":1775327534277,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4789,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/modpathol.2009.131","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T10:59:44Z","timestamp":1253271584000},"page":"1532-1540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Immunomodulator agent-related lymphoproliferative disorders"],"prefix":"10.1016","volume":"22","author":[{"given":"Robert P","family":"Hasserjian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherrie L","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha C","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd S","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan S","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.131_bib1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2146\/ajhp060365","article-title":"Use of biologics in rheumatoid arthritis: where are we going?","volume":"63","author":"Pucino","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1038\/modpathol.2009.131_bib2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1038\/modpathol.2009.131_bib3","first-page":"2250","article-title":"Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice","volume":"22","author":"Van Lent","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1038\/modpathol.2009.131_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-007-0467-6","article-title":"Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment","volume":"28","author":"Park","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1038\/modpathol.2009.131_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000095037","article-title":"A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis","volume":"213","author":"Leonardi","year":"2006","journal-title":"J Dermatol"},{"key":"10.1038\/modpathol.2009.131_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2007.085852","article-title":"Anti-TNF therapy in RA and risk of malignant lymphomas Relative risks and time-trends in the Swedish Biologics Register","volume":"68","author":"Askling","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/modpathol.2009.131_bib7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumor necrosis factor treatments in rheumatoid arthritis: meta and exposure adjusted pooled analyses of serious adverse events","volume":"68","author":"Leombruno","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/modpathol.2009.131_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2009.131_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.131_bib10","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"350","article-title":"Other iatrogenic immunodeficiency-associated lymphoproliferative disordersd","author":"Gaulard P","year":"2008"},{"key":"10.1038\/modpathol.2009.131_bib11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2009.131_bib12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/02M7-5JCC-YRTK-MGDR","article-title":"T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently labeled PCR products","volume":"113","author":"Sprouse","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.131_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/modpathol.2009.131_bib14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMcpc059035","article-title":"Case 8-2006: A 71-year-old woman with Crohn's disease and altered mental status","volume":"354","author":"Podolsky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.131_bib15","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/modpathol.2009.131_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.2004.051771","article-title":"Risk of haematopoietic cancer in patients with inflammatory bowel disease","volume":"54","author":"Askling","year":"2005","journal-title":"Gut"},{"key":"10.1038\/modpathol.2009.131_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","article-title":"Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study","volume":"317","author":"Baecklund","year":"1998","journal-title":"BMJ"},{"key":"10.1038\/modpathol.2009.131_bib18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","article-title":"Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma","volume":"48","author":"Baecklund","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1038\/modpathol.2009.131_bib19","first-page":"1676","article-title":"A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis","volume":"26","author":"Kamel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1038\/modpathol.2009.131_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.131_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/modpathol.2009.131_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1746-1596-3-13","article-title":"A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagonists","volume":"3","author":"Hurley","year":"2008","journal-title":"Diagn Pathol"},{"key":"10.1038\/modpathol.2009.131_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Derm"},{"key":"10.1038\/modpathol.2009.131_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaad.2004.03.047","article-title":"Aggressive cutaneous T-cell lymphomas after TNF-alpha blockade","volume":"51","author":"Adams","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/modpathol.2009.131_bib25","first-page":"810","article-title":"Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease","volume":"27","author":"Moseley","year":"2000","journal-title":"J Rheumtol"},{"key":"10.1038\/modpathol.2009.131_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J Immunol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:59:39Z","timestamp":1760230779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0893395222024243"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.131","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulator agent-related lymphoproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}